[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100501974":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":30,"locations":36,"responsibleParty":54,"collaborators":26,"id":58,"slug":59,"hasResults":60,"nctId":61,"briefTitle":62,"officialTitle":63,"acronym":26,"eligibilityCriteria":64,"healthyVolunteers":60,"sex":65,"minAge":66,"maxAge":26,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":39,"whyStopped":26,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"University of the Pacific","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Hydrocortisone topical","EXPERIMENTAL","2.5% hydrocortisone cream",[13],"Drug: Hydrocortisone 2.5%",{"label":15,"type":16,"description":17,"interventionNames":18},"Diclofenac topical","ACTIVE_COMPARATOR","1% diclofenac cream",[19],"Drug: Diclofenac 1% topical",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Hydrocortisone 2.5%","Applied four times daily to TMJ with arthralgia",[9],null,{"type":22,"name":28,"description":24,"armGroupLabels":29,"otherNames":26},"Diclofenac 1% topical",[15],[31],{"name":32,"role":33,"phone":34,"phoneExt":26,"email":35},"Andrew Young, DDS, MSD","CONTACT","4153517126","ayoung@pacific.edu",[37],{"facility":38,"status":39,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Arthur A. Dugoni School of Dentistry, University of the Pacific","RECRUITING","San Francisco","California","94103","United States","US",{"type":46,"coordinates":47},"Point",[48,49],-122.41942,37.77493,{"lat":49,"lon":48},[52],{"name":32,"role":33,"phone":53,"phoneExt":26,"email":35},"4159296611",{"type":55,"investigatorFullName":56,"investigatorTitle":57,"investigatorAffiliation":5,"oldNameTitle":26,"oldOrganization":26},"PRINCIPAL_INVESTIGATOR","Andrew Young","Assistant Professor, Department of Diagnostic Sciences","100501974","phase-3-topical-treatment-for-tmj-arthralgia-100501974",false,"NCT05816226","Topical Treatment for TMJ Arthralgia","Comparison of Topical 1% Diclofenac and Topical 2.5% Hydrocortisone for TMJ Arthralgia","Inclusion Criteria:\n\n* Arthralgia of at least 1 TMJ for at least 3 days\n\nExclusion Criteria:\n\n* Systemic pain condition\n* Past adverse reaction to steroid\n* Currently taking steroid\n* Taken steroid in the past \\_\\_\\_ months\n* Muscle relaxants (may start after study is complete)\n* New night guard during study, or within 1 month of start of study (may start after study is complete)","ALL","18 Years",{"count":68,"type":69},90,"ESTIMATED","INTERVENTIONAL",[72],"PHASE3","The goal of this clinical trial is to evaluate the efficacy of topical 2.5% hydrocortisone in TMJ arthralgia. The main questions it aims to answer are:\n\n* How does pain reduction compare?\n* How does improvement in jaw function limitation compare?\n* How do side effects compare? Participants will\n* On day 1 be examined and report their pain level and jaw function limitation\n* On days 1-21, apply their cream four times a day\n* On day 21, report their pain level, jaw function limitation, compliance with instructions, and side effects.\n\nResearchers will compare topical 2.5% hydrocortisone and topical 1% diclofenac to see if efficacy and side effects differ.",[75],"TMJ Pain",[77,78,79,80],"diclofenac","hydrocortisone","TMJ","arthralgia","2024-12-05",{"date":83,"type":84},"2024-12-11","ACTUAL",{"date":86,"type":84},"2023-06-01",{"date":88,"type":69},"2026-04",{"name":5,"class":6},1]